Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SPRB
SPRB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRB News
Precious Metals Stocks Surge, Led by Aura Minerals
5d ago
NASDAQ.COM
SPRUCE BIOSCIENCES INC - TERMINATION OF ALL LICENSES AND RIGHTS GRANTED TO KAKEN; NO UNRECEIVED MILESTONE PAYMENTS OR ROYALTIES DUE
Mar 20 2026
moomoo
SPRUCE BIOSCIENCES INC ANNOUNCES TERMINATION AGREEMENT WITH KAKEN PHARMACEUTICAL ON MARCH 16 - SEC FILING
Mar 20 2026
moomoo
Spruce Biosciences Reports Disappointing FY EPS and Cash Position
Mar 09 2026
seekingalpha
Spruce Biosciences Advances TA-ERT for MPS IIIB Treatment
Mar 09 2026
Newsfilter
Spruce Biosciences Delays FDA Submission Timeline
Feb 18 2026
stocktwits
SPRUCE BIOSCIENCES STOCK JUMPS 8.16% AS COMPANY PREPARES FOR FDA FILING ON RARE PEDIATRIC BRAIN DISORDER TREATMENT
Feb 18 2026
moomoo
Spruce Biosciences Reports Positive FDA Meeting Outcomes for TA-ERT
Feb 18 2026
NASDAQ.COM
Spruce Biosciences Advances TA-ERT BLA Submission Following FDA Feedback
Feb 18 2026
Newsfilter
Harbour BioMed Exercises Warrant to Acquire 3.8% of Spruce Biosciences Inc.
Jan 21 2026
Benzinga
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences (SPRB)
Jan 19 2026
NASDAQ.COM
Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences
Jan 19 2026
PRnewswire
Harbour BioMed Acquires 3.8% of Spruce Biosciences, Enhancing Strategic Partnership
Jan 19 2026
Newsfilter
Spruce Biosciences Secures $15 Million Loan to Support MPS IIIB Treatment Development
Jan 08 2026
Newsfilter
Cellectis SA Receives Buy Rating with $9 Price Target from Clear Street
Dec 23 2025
Benzinga
Spruce Biosciences Appoints Keli Walbert to Board, Aiming for TA-ERT Launch
Dec 15 2025
Newsfilter
Show More News
